These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11087570)

  • 1. Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxo-hexahydro-pyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 1. The alpha-methyl-trans-lactam template.
    Borthwick AD; Angier SJ; Crame AJ; Exall AM; Haley TM; Hart GJ; Mason AM; Pennell AM; Weingarten GG
    J Med Chem; 2000 Nov; 43(23):4452-64. PubMed ID: 11087570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality.
    Borthwick AD; Crame AJ; Ertl PF; Exall AM; Haley TM; Hart GJ; Mason AM; Pennell AM; Singh OM; Weingarten GG; Woolven JM
    J Med Chem; 2002 Jan; 45(1):1-18. PubMed ID: 11754575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.
    Borthwick AD; Davies DE; Ertl PF; Exall AM; Haley TM; Hart GJ; Jackson DL; Parry NR; Patikis A; Trivedi N; Weingarten GG; Woolven JM
    J Med Chem; 2003 Oct; 46(21):4428-49. PubMed ID: 14521407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of ethyl pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease.
    Slater MJ; Andrews DM; Baker G; Bethell SS; Carey S; Chaignot H; Clarke B; Coomber B; Ellis M; Good A; Gray N; Hardy G; Jones P; Mills G; Robinson E
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3359-62. PubMed ID: 12419361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of translactam HCMV protease inhibitors as potent antivirals.
    Borthwick AD
    Med Res Rev; 2005 Jul; 25(4):427-52. PubMed ID: 15789440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses of trans-5-oxo-hexahydro-pyrrolo[3,2-b]pyrroles and trans-5-oxo-hexahydro-furo[3,2-b]pyrroles (pyrrolidine trans-lactams and trans-lactones): new pharmacophores for elastase inhibition.
    Macdonald SJ; Belton DJ; Buckley DM; Spooner JE; Anson MS; Harrison LA; Mills K; Upton RJ; Dowle MD; Smith RA; Molloy CR; Risley C
    J Med Chem; 1998 Oct; 41(21):3919-22. PubMed ID: 9767628
    [No Abstract]   [Full Text] [Related]  

  • 7. Design and synthesis of monocyclic beta-lactams as mechanism-based inhibitors of human cytomegalovirus protease.
    Borthwick AD; Weingarten G; Haley TM; Tomaszewski M; Wang W; Hu Z; Bedard J; Jin H; Yuen L; Mansour TS
    Bioorg Med Chem Lett; 1998 Feb; 8(4):365-70. PubMed ID: 9871686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrrolidine-5,5-trans-lactams. 1. Synthesis and incorporation into inhibitors of hepatitis C virus NS3/4A protease.
    Andrews DM; Carey SJ; Chaignot H; Coomber BA; Gray NM; Hind SL; Jones PS; Mills G; Robinson JE; Slater MJ
    Org Lett; 2002 Dec; 4(25):4475-8. PubMed ID: 12465916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability.
    Borthwick AD; Exall AM; Haley TM; Jackson DL; Mason AM; Weingarten GG
    Bioorg Med Chem Lett; 2002 Jul; 12(13):1719-22. PubMed ID: 12067545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Lactam derivatives as inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Guse I; Haché B; Naud J; O'Meara JA; Plante R; Déziel R
    J Med Chem; 1998 Jul; 41(15):2882-91. PubMed ID: 9667976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of spiro-cyclopentenyl and spiro-[1,3]-dithiolanyl substituted pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease.
    Andrews DM; Jones PS; Mills G; Hind SL; Slater MJ; Trivedi N; Wareing KJ
    Bioorg Med Chem Lett; 2003 May; 13(10):1657-60. PubMed ID: 12729635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal mediated protease inhibition: design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease.
    Dhanak D; Burton G; Christmann LT; Darcy MG; Elrod KC; Kaura A; Keenan RM; Link JO; Peishoff CE; Shah DH
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2279-82. PubMed ID: 11055338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic insights into the inhibition of serine proteases by monocyclic lactams.
    Wilmouth RC; Kassamally S; Westwood NJ; Sheppard RJ; Claridge TD; Aplin RT; Wright PA; Pritchard GJ; Schofield CJ
    Biochemistry; 1999 Jun; 38(25):7989-98. PubMed ID: 10387042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent beta-lactam inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Grand-Maître C; Guse I; Haché B; Kawai S; Naud J; O'Meara JA; Plante R; Déziel R
    Antivir Chem Chemother; 1998 Sep; 9(5):379-87. PubMed ID: 9875391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From 1-acyl-beta-lactam human cytomegalovirus protease inhibitors to 1-benzyloxycarbonylazetidines with improved antiviral activity. A straightforward approach to convert covalent to noncovalent inhibitors.
    Gerona-Navarro G; Pérez de Vega MJ; García-López MT; Andrei G; Snoeck R; De Clercq E; Balzarini J; González-Muñiz R
    J Med Chem; 2005 Apr; 48(7):2612-21. PubMed ID: 15801851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the covalent modification of the catalytic triad of human cytomegalovirus protease by pseudo-reversible beta-lactam inhibitors and a peptide chloromethylketone.
    Haley TM; Angier SJ; Borthwick AD; Montgomery DS; Purvis IJ; Smart DH; Bessant C; Van Wely C; Hart GJ
    J Mass Spectrom; 1998 Dec; 33(12):1246-55. PubMed ID: 9875526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors.
    Ghosh AK; Xi K; Ratia K; Santarsiero BD; Fu W; Harcourt BH; Rota PA; Baker SC; Johnson ME; Mesecar AD
    J Med Chem; 2005 Nov; 48(22):6767-71. PubMed ID: 16250632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anti-HCMV activity of 1-acyl-beta-lactams and 1-acylazetidines derived from phenylalanine.
    Gerona-Navarro G; Pérez de Vega MJ; García-López MT; Andrei G; Snoeck R; Balzarini J; De Clercq E; González-Muñiz R
    Bioorg Med Chem Lett; 2004 May; 14(9):2253-6. PubMed ID: 15081019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of further pyrrolidine trans-lactams as inhibitors of human neutrophil elastase (HNE) with potential as development candidates and the crystal structure of HNE complexed with an inhibitor (GW475151).
    Macdonald SJ; Dowle MD; Harrison LA; Clarke GD; Inglis GG; Johnson MR; Shah P; Smith RA; Amour A; Fleetwood G; Humphreys DC; Molloy CR; Dixon M; Godward RE; Wonacott AJ; Singh OM; Hodgson ST; Hardy GW
    J Med Chem; 2002 Aug; 45(18):3878-90. PubMed ID: 12190311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human cytomegalovirus protease N(o) with monocyclic beta-lactams.
    Déziel R; Malenfant E
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1437-42. PubMed ID: 9871780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.